Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is rated as an Elite provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy.

Behnood Bikdeli is a Cardiologist in Boston, Massachusetts. Dr. Bikdeli has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Thrombectomy, and Percutaneous Coronary Intervention (PCI).

Lindsey Baden is an Infectious Disease provider in Boston, Massachusetts. Dr. Baden is rated as an Elite provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and HIV/AIDS. Dr. Baden is currently accepting new patients.

Samuel Goldhaber is a Cardiologist in Boston, Massachusetts. Dr. Goldhaber is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

Dr. Li is an infectious disease physician-scientist at the Brigham and Women’s Hospital and Harvard Medical School.  He leads an active clinical and translational laboratory research program focused on viral detection, reservoirs and resistance, especially within the fields of HIV and COVID-19.Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the AIDS Clinical Trials Group (ACTG) Executive Committee. He is the protocol co-Chair of the ACTG A5308 study of ART treatment for HIV-1 controllers, the co-Chair of the A5345 study of biomarkers of HIV rebound, and the protocol virologist for A5401/ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. Dr. Li also serves as the Deputy Editor for the Infectious Disease Society of America (IDSA) journal Open Forum Infectious Diseases and on the Editorial Advisory Board for the Journal of Infectious Diseases. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are HIV/AIDS, COVID-19, Sepsis, Prostatectomy, and Nephrectomy.

Brett Carroll is an Internal Medicine provider in Boston, Massachusetts. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pulmonary Embolism, Meige Disease, Primary Intestinal Lymphangiectasia, Embolectomy, and Thrombectomy.

Umberto Campia is a Cardiologist in Boston, Massachusetts. Dr. Campia is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pulmonary Embolism, Aortic Dissection, Cystic Medial Necrosis of Aorta, COVID-19, and Cardiac Ablation.

Patrick Lawler is a Cardiologist in Boston,, Massachusetts. Dr. Lawler is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cardiogenic Shock, COVID-19, Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Zaid Almarzooq is a Cardiologist in Boston, Massachusetts. Dr. Almarzooq is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Heart Attack, Partial Atrioventricular Canal, Embolectomy, and Transcatheter Aortic Valve Replacement (TAVR).

Dimitrios Farmakiotis is an Internal Medicine provider in Boston, Massachusetts. Dr. Farmakiotis is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Sepsis, Cytomegalovirus Infection, and Cytomegalic Inclusion Disease.

Dr. Bruce David Levy is the division chief of the Pulmonary and Critical Care Medicine Division and chair of the Department of Medicine at Brigham and Women’s Hospital (BWH). He is also the Hersey Professor of Theory and Practice of Physic at Harvard Medical SchoolHe received his medical degree from the University of Pennsylvania School of Medicine (now the Perelman School of Medicine). He then completed a chief medical residency at the Brockton Campus of the VA Boston Healthcare System , followed by a residency in internal medicine, a chief medical residency, and a fellowship in pulmonary and critical care medicine at BWH. He is board certified in critical care medicine and pulmonary disease.Dr. Levy’s clinical interests include acute respiratory distress syndrome, asthma, bronchiectasis and chronic obstructive pulmonary disease. His laboratory aims to identify new pathways to resolve pulmonary inflammation or injury through the roles of endogenous counter-regulatory mediators in the lung, and his work has helped lead to over 10 patents awarded or pending. He has written more than 120 peer-reviewed publications, has received funding from the National Institutes of Health, and currently serves as associate editor of the American Journal of Respiratory and Critical Care Medicine and The New England Journal of Medicine's clinical problem-solving interactive case series. Dr. Levy is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Asthma, Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Endoscopy, and Gastric Bypass.

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS). He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease. Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management. Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors. Dr. Morrow is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Victor Nauffal, MD, MSc, serves as the Director of the Inherited Arrhythmia Clinic and is a Staff Cardiac Electrophysiologist within the Division of Cardiovascular Medicine at Brigham and Women’s Hospital.Dr. Nauffal's clinical expertise encompasses all clinical arrhythmias and includes advanced procedural skills in complex catheter ablation for atrial and ventricular arrhythmias, ablation of premature ventricular contractions, management of the left atrial appendage, and the implantation of pacemakers and implantable cardioverter defibrillators. He is dedicated to delivering exemplary patient care by leveraging state-of-the-art technology and research to optimize treatment outcomes.A particular area of passion for Dr. Nauffal is cardiovascular genetics and inherited arrhythmias. His research is focused on unraveling the molecular mechanisms underlying cardiac arrhythmias and cardiac fibrosis using genetic studies, with the goal of improving early diagnosis, risk stratification, and personalized treatment approaches. He earned a Master of Science in Statistical Genetics and Genetic Epidemiology from the Harvard T.H. Chan School of Public Health and is an Affiliate Scientist within the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard. Dr. Nauffal has authored over 40 peer-reviewed articles in prestigious journals such as Nature Medicine, Nature Genetics, Circulation, the Journal of the American College of Cardiology, and the European Heart Journal.At the Inherited Arrhythmia Clinic, Dr. Nauffal specializes in managing patients with inherited arrhythmia syndromes and collaborates closely with genetic counselors to merge clinical insights with genetic findings, thereby enriching the understanding and management of these complex disorders. Dr. Nauffal is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Atrial Fibrillation, Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Dr. Mandeep R. Mehra is the medical director of the Brigham and Women’s Hospital (BWH) Heart and Vascular Center and the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine. He specializes in cardiovascular medicine and cardiac transplant at BWH and is a professor of medicine at Harvard Medical School.Dr. Mehra received his medical degree from Mahatma Gandhi Institute of Medical Sciences in Maharashtra, India. He completed a residency in internal medicine at Mount Carmel Medical Center in Columbus, as well as fellowships in cardiovascular disease and advanced heart failure and transplant cardiology at Ochsner Clinic Foundation Hospital in New Orleans. Dr. Mehra is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.Dr. Mehra’s clinical interests include advanced heart failure and cardiac transplantation. The author of over 200 peer-reviewed publications, his research has received support from the National Heart, Lung and Blood Institute. His recent studies focus on immunosuppression, proteomic and genomic biomarkers in peripheral blood for the prediction of cardiac rejection, as well as the effects of tobacco exposure on donor and recipient heart outcomes. Dr. Mehra is also editor-in-chief of The Journal of Heart and Lung Transplantation. Dr. Mehra is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Heart Failure, COVID-19, Ventricular Fibrillation, Heart Transplant, and Thrombectomy.

Dr. Chanu Rhee is an infectious disease and critical care physician, Medical Director of Infection Control at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital followed by an infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and an MPH degree from the Harvard T.H. Chan School of Public Health. Dr. Rhee is internationally recognized for his expertise and contributions to the epidemiology, surveillance, diagnosis, and treatment of sepsis, particularly through the innovative use of electronic health record data to generate insights that inform clinical practice, quality improvement, and public health policy. His areas of focus also include infection prevention and control, antimicrobial resistance and stewardship, infections in immunocompromised patients, and the care of critically ill patients. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham healthcare system and has participated in many national committees focused on enhancing sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.Dr. Rhee attends clinically on the transplant / oncology infectious disease service and the Medical ICU at Brigham and Women’s Hospital. In his role as Medical Director of Infection Control, he leads institutional efforts to prevent healthcare-associated infections, investigate outbreaks, and advance patient safety. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine. He has served as principal or lead investigator on multiple federally funded grants, has authored over 200 peer-reviewed articles, and is recognized by ScholarGPS as one of the world’s most highly cited and influential experts on sepsis. Dr. Rhee is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Sepsis, Severe Acute Respiratory Syndrome (SARS), Hospital-Acquired Pneumonia, and Pneumonia.

Pritha Sen is an Infectious Disease provider in Boston, Massachusetts. Dr. Sen has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), and Cytomegalovirus Infection.

Ann Woolley is an Infectious Disease provider in Boston, Massachusetts. Dr. Woolley is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and Splenectomy.

Jane Newburger is a Pediatrics provider in Boston, Massachusetts. Dr. Newburger is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Congenital Heart Disease (CHD), Heart Transplant, and Thrombectomy.